Taiwan FDA registration 3b2ab5f794f7f4ad82934585a6e6f5e1
"Baidoli" Osilo second generation sirolimus coronary artery coating stent system
TW: “百多力”歐禧樂第二代西羅莫司冠狀動脈塗藥支架系統
Taiwan·Risk Class 3·BIOTRONIK AG·Registered Jan 06, 2021 – Jan 06, 2026ExpiredRegistration details
- Analysis ID
- 3b2ab5f794f7f4ad82934585a6e6f5e1
- Customs Code
- DHA05603424304
Company information
- Manufacturer
- BIOTRONIK AG
- Manufacturer Country
- Switzerland
- Authorized Representative
- BIOTRONIK TAIWAN LIMITED
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- E Cardiovascular Medicine Science
- Product Type (Level 2)
- E.0001 Cardiovascular stents
- Import Information
- import
Dates and status
- Registration Date
- Jan 06, 2021
- Expiry Date
- Jan 06, 2026
About this record
Access comprehensive regulatory information for "Baidoli" Osilo second generation sirolimus coronary artery coating stent system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 3b2ab5f794f7f4ad82934585a6e6f5e1 and manufactured by BIOTRONIK AG. The authorized representative in Taiwan is BIOTRONIK TAIWAN LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices